165—71.
74. Zatonski WA, Lowenfels AB, Boyle P, Maisonneuve P, Bueno de Mesquita HB, Ghadirian P, Jain M, Przewozniak K, Baghurst P, Moerman CJ, Simard A, Howe GR, et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst 1997; 89: 1132—8.
75. Purslow LR, Sandhu MS, Forouhi N, et al. Energy Intake at Breakfast and Weight Change: Prospective Study of 6,764 Middle-aged Men and Women. Am J Epidemiol 2007; Dec 12
76. Jemal A, Bray F, Center MM et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.
77. Vanni E, Bugianesi E, Kotronen A et al. From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 2010; 42: 320–330.
78. Ludwig DS. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 2002; 287: 2414–2423.
79. Augustin LS, Franceschi S, Jenkins DJ et al. Glycemic index in chronic disease: a review. Eur J Clin Nutr 2002; 56: 1049–1071.
80. Saunders D, Seidel D, Allison M et al. Systematic review: the association between obesity and hepatocellular carcinoma – epidemiological evidence. Aliment pharmacol Ther 2010; 31: 1051–1063.
81. Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer 2007; 97: 1005–1008.
82. WCRF/AICR. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR 2007.
83. Schlesinger S, Aleksandrova K, Pischon T et al. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. Int J Cancer 2012; doi: 10.1002/ijc.27645.
84. Ren HB, Yu T, Liu C et al. Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis. Cancer Causes Control 2011; 22: 837–847.
85. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006; 4: 369–380.
86. Aleksandrova K, Pischon T, Buijsse B, May AM, Peeters PH, Bueno-de-Mesquita HB, Jenab M, Fedirko V, Dahm CC, Siersema PD, Freisling H, Ferrari P, Overvad K, Tjønneland A, Trichopoulou A, Lagiou P, Naska A, Pala V, Mattiello A, Ohlsson B, Jirström K, Key TJ, Khaw KT, Riboli E, Boeing H. Adult weight change and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Eur J Cancer. 2013 Nov; 49(16): 3526–36. doi: 10.1016/j.ejca.2013.06.021. Epub 2013 Jul 15.
87. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC. Calorie restriction, aging, and cancer prevention: mechanism of action and applicability to humans. Annu Rev Med 2003, 54: 131–152.
88. Dirx MJ, Zeegers MP, Dagnelie PC, van den Bogaard T, van den Brandt PA. Energy restriction and the risk of spontaneous mammary tumours in mice: a meta-analysis. Int J Cancer 2003, 106: 766–770.
89. Harvell DM, Strecker TE, Xie B, Pennington KL, McComb RD, Shull JD. Dietary energy restriction inhibits estrogen-induced mammary, but not pituitary, tumorigenesis in the ACI rat. Carcinogenesis 2002, 23: 161–169.
90. Matsuzaki J, Yamaji R, Kiyomya K, Kurebe M, Inui H, Nakano Y. Implanted tumor growth is suppressed and survival is prolonged in sixty percent of food-restricted mice. J Nutr 2000, 130: 11–115.
91. Michels KB, Ekbom A. Caloric restriction and incidence of breast cancer. Jama 2004, 291: 1226–1230.
92. Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values:2002. Am J Clin Nutr 2002, 76:5–56.
93. Augustin LS, Gallus S, Negri E, La Vecchia C. Glycemic index, glycemic load and risk of gastric cancer. Ann Oncol 2004, 15:581–584.
94. Augustin LS, Gallus S, Bosetti C, Levi F, Negri E, Jenkins DJ, Kendall CW, Maso L, Talamini R, La Vecchia C. Glycemic index and load and risk of upper-aerodigestive tract neoplasm. Cancer Causes Control 2003, 14: 657–662.
95. Augustin LS, Gallus S, Bosetti C, Levi F, Negri E, Franceschi S, Dal Maso L, Jenkins DJ, Kendall CW, La Vecchia C. Glycemic index and glycemic load in endometrial cancer. Int J Cancer 2003, 105: 404–407.
96. Franceschi S, Dal Maso L, Augustin L, Negri E, Parpinel M, Boyle P, Jenkins DJ, La Vecchia C. Dietary glycemic load and colorectal cancer risk. Ann Oncol 2001, 12: 173–178.
97. Augustin LS, Polesel J, Bosetti C, Kendall CW, La Vecchia C, Parpinel M, Conti E, Montella M, Franceschi S, Jenkins DJ, Dal Maso L. Dietary glycemic index, glycemic load and ovarian cancer risk: a case-control study in Italy. Ann Oncol 2003, 14: 78–84.
98. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002, 11: 385–391.
99. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am I Epidemiol 2004, 159: 1160–1169
100. La Vecchia C, Negri E, Decarli A, Franceschi S. Diabete mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1997, 6: 1007–1010.
101. Sandhu MS, Luben R, Khaw KT. Self reported non-unsulin dependent diabetes, family history, and risk of prevalent colorectal cancer: population based, cross sectional study. J Epidemiol Community Health 2001, 55: 804–805.
102. Anderson KE, Anderson E, Mink PJ, Hong CP, Kushi LH, Sellers TA, Lazovich D, Folsom AR. Diabetes and endometrial cancer in the Iowa women`s health study. Cancer Epidemiol Biomarkers Prev 2001, 10: 611–616.
103. Cale EE, Murphy TK, Rodriguez C, Thun MJ, Heath CW. Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults. Cancer Causes Control 1998, 9: 403–410.
104. Finegold SM, Sutter VL, Sugihara PT, Elder HA, Lehmann SM, Phillips RL. Fecal microbial flora in Seventh Day Adventist Populations and control subjects. Am J Clin Nutr 1977; 30: 1781–1792.
105. Moore WE, Moore LH. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 1995; 61: 3202–3207.
106. Goldin PR, Gorbach SL. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 1984; 39: 756–761.
107. Aso Y, Akazan H. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group. Urol Int 1992; 49: 125–129.
108. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol 1995; 27: 104–109.
109. Flint HJ. Nutr Rev 2012; 70 Suppl1: S10–S13 (World Cancer Report 2014).
110. Tremaroli V, Backhed F. Nature 2012; 489: 242–249 (World Cancer Report 2014).
111. Commane D, Hughes R, Shortt C, Rowland I. The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mutat Res /Fundam Mol Mech Mutagen 2005; 591: 276–89.
112. Kumar M, Kumar A, Nagpal R, Mohania D, Behare P, Verma V, Kumar P, Poddar